TSUI WAH HLDG (01314) issued a profit warning, expecting a year-on-year decline in net profit of 50%-70%.
Suixing Holdings (01314) announced that it had a profit of about 39 million Hong Kong dollars for the financial year ending on March 31, 2024.
TSUI WAH HLDG(01314) announced that compared to the net profit attributable to owners of the company of approximately HK$39 million for the financial year ending March 31, 2024, the group's net profit for the financial year ending March 31, 2025 is expected to decrease by no less than 50% but not more than 70%.
The board of directors believes that the expected decrease is mainly due to the less than ideal economic environment in Hong Kong and mainland China; an increase in inbound tourism to Hong Kong; intense competition in the mainland China restaurant industry; and the impact of the US-China trade war.
Related Articles

Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.

China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.

Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.

China Post Securities: The cost-effectiveness of consumer building materials is highlighted, focusing on low-end varieties of domestic demand.

Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.

RECOMMEND





